businesspress24.com - Immunotec Announces a Corporate Update
 

Immunotec Announces a Corporate Update

ID: 1237135

(firmenpresse) - VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 06/14/13 -- Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Corporation" or "Immunotec") announced today that at a meeting of its board of directors (the "Board") held on this date, the Board approved the following matters:

About Immunotec Inc.

Immunotec is a world-class business opportunity supported by unique, scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Corporation also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Mexico, Europe and the Caribbean.

The Corporation files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Corporation's website at . The Shares are listed on the TSX Venture Exchange under the ticker symbol IMM.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at . Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Patrick Montpetit
Chief Financial Officer




(450) 510-4527


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Immunotec Announces Second Quarter 2013 Financial Results
Health Enhancement Products, Inc. Receives Notice of Allowance From US Patent Office for Treatment of Disease Using Its Proprietary Algal Phyto-Percolate and Files Two New Patent Applications for Animal Health
Bereitgestellt von Benutzer: Marketwired
Datum: 14.06.2013 - 14:16 Uhr
Sprache: Deutsch
News-ID 1237135
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

VAUDREUIL-DORION, QUEBEC


Phone:

Kategorie:

Health & Nutrition


Anmerkungen:


Diese Pressemitteilung wurde bisher 167 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Immunotec Announces a Corporate Update
"
steht unter der journalistisch-redaktionellen Verantwortung von

Immunotec Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Immunotec Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 53


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.